Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience (TWST)
:TWST
Total Valuation
Twist Bioscience has a market cap or net worth of $2.38B. The enterprise value is $2.56B.
Market Cap$2.38B
Enterprise Value$2.56B
Share Statistics
Twist Bioscience has 59.65M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59.65M
Owned by Insiders3.17%
Owned by Instutions0.08%
Financial Efficiency
Twist Bioscience’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -38.65%.
Return on Equity (ROE)-44.16%
Return on Assets (ROA)-33.98%
Return on Invested Capital (ROIC)-38.65%
Return on Capital Employed (ROCE)-40.64%
Revenue Per Employee$357,734.561
Profits Per Employee-$213,772.481
Employee Count923
Asset Turnover0.51
Inventory Turnover7.46
Valuation Ratios
The current PE Ratio of Twist Bioscience is -12.56. Twist Bioscience’s PEG ratio is 0.00.
PE Ratio-12.56
PS Ratio8.38
PB Ratio5.55
Price to Fair Value5.55
Price to FCF-37.89
Price to Operating Cash Flow-40.90
PEG Ratio0.00
Income Statement
In the last 12 months, Twist Bioscience had revenue of $330.19M and earned -$197.31M in profits. Earnings per share was -$3.39.
Revenue$330.19M
Gross Profit$147.23M
Operating Income-$208.50M
Pretax Income-$196.78M
Net Income-$197.31M
EBITDA-167.09M
Earnings Per Share (EPS)-3.39
Cash Flow
In the last 12 months, operating cash flow was -$62.55M and capital expenditures -$5.84M, giving a free cash flow of -$68.39M billion.
Operating Cash Flow-$62.55M
Free Cash Flow-$68.39M
Free Cash Flow per Share-$1.15
Dividends & Yields
Twist Bioscience pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-2.64%
Earnings Yield-7.96%
Stock Price Statistics
Beta3.08
52-Week Price Change39.18%
50-Day Moving Average42.26
200-Day Moving Average45.58
Relative Strength Index (RSI)49.83
Average Volume (3m)1.33M
Important Dates
Twist Bioscience upcoming earnings date is May 5, 2025, After Close.
Last Earnings DateFeb 3, 2025
Next Earnings DateMay 5, 2025
Ex-Dividend Date―
Financial Position
Twist Bioscience as a current ratio of 4.88, with Debt / Equity ratio of 0.18
Current Ratio4.88
Quick Ratio4.54
Debt to Market Cap<0.01
Net Debt to EBITDA0.80
Interest Coverage Ratio-7.61K
Taxes
In the past 12 months, Twist Bioscience has paid $537.00K in taxes.
Income Tax$537.00K
Effective Tax Rate-0.27%
Enterprise Valuation
Twist Bioscience EV to EBITDA ratio is -14.03, with an EV/FCF ratio of -35.85.
EV to Sales7.92
EV to EBITDA-14.03
EV to Free Cash Flow-35.85
EV to Operating Cash Flow-38.69
Balance Sheet
Twist Bioscience has $270.83M in cash and marketable securities with $82.62M in debt, giving a net cash position of -$188.21M billion.
Cash & Marketable Securities$270.83M
Total Debt$82.62M
Net Cash-$188.21M
Net Cash Per Share-$3.16
Tangible Book Value Per Share$6.42
Margins
Gross margin is 42.61%, with operating margin of -70.56%, and net profit margin of -66.69%.
Gross Margin42.61%
Operating Margin-70.56%
Pretax Margin-66.51%
Net Profit Margin-66.69%
EBITDA Margin-56.46%
EBIT Margin-66.50%
Analyst Forecast
The average price target for Twist Bioscience is $51.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$51.00
Price Target Upside28.08%
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast25.85%
EPS Growth Forecast6.06%